Manawatu Investment Group has invested $1 million into a Palmerston North biotech start-up company. 

Polybatics designs biodegradable nano particles with functional proteins attached, which is used to manufacture pharmaceutical drugs. This new organic nanotechnology could drastically reduce the price of medication and make it more accessible.

It allows for biobeads to be manufactured on a large scale quickly and cheaply, and has potential in a variety of industries from vaccines to washing powders and food processing.